Abstract: . . .  respectively), or 4) vessels of the placenta (miscarriage). Patients with lupus kidney disease (lupus nephritis) who lose a lot of protein in their urine may also be hyper- coaguable. Patients who have had blood clots are typically treated with anticoagulants (medicines that prevent clot formation) such as heparin and coumadin. T HE F UTURE Vascular biology is an exciting field, and it is assured that a greater understanding of the vascular system in SLE will arise from current and future research efforts. This will no doubt eventually result in safer and more effective therapies to deal with autoimmune diseases like SLE. 8 2003 Lupus Alliance of America, Inc.  . . .
. . .  coaguable. Patients who have had blood clots are typically treated with anticoagulants (medicines that prevent clot formation) such as heparin and coumadin. T HE F UTURE Vascular biology is an exciting field, and it is assured that a greater understanding of the vascular system in SLE will arise from current and future research efforts. This will no doubt eventually result in safer and more effective therapies to deal with autoimmune diseases like SLE. 8 2003 Lupus Alliance of America, Inc.  . . .
--2039,2,510,1519,10197